BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3258205)

  • 1. Anti-idiotypic induced suppression of Sjögren's syndrome associated anti-La autoantibody secretion in vitro.
    Horsfall AC; Mumford PA; Venables PJ; Maini RN
    Clin Exp Immunol; 1988 Jan; 71(1):62-6. PubMed ID: 3258205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiotypes on antibodies to the La (SS-B) antigen are restricted and associated with the antigen binding site.
    Horsfall AC; Venables PJ; Mumford PA; Maini RN
    Clin Exp Immunol; 1986 Feb; 63(2):395-401. PubMed ID: 3486064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs).
    Tzioufas AG; Hantoumi I; Polihronis M; Xanthou G; Moutsopoulos HM
    J Autoimmun; 1999 Dec; 13(4):429-34. PubMed ID: 10585759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253.
    Lisi S; Sisto M; Soleti R; Saponaro C; Scagliusi P; D'Amore M; Saccia M; Maffione AB; Mitolo V
    J Oral Pathol Med; 2007 Oct; 36(9):511-23. PubMed ID: 17850433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-La antibodies.
    St Clair EW
    Rheum Dis Clin North Am; 1992 May; 18(2):359-76. PubMed ID: 1626074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate T cell epitopes of the human La/SSB autoantigen.
    Davies ML; Taylor EJ; Gordon C; Young SP; Welsh K; Bunce M; Wordsworth BP; Davidson B; Bowman SJ
    Arthritis Rheum; 2002 Jan; 46(1):209-14. PubMed ID: 11817592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
    Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
    J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.
    Harley JB; Alexander EL; Bias WB; Fox OF; Provost TT; Reichlin M; Yamagata H; Arnett FC
    Arthritis Rheum; 1986 Feb; 29(2):196-206. PubMed ID: 3485431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiotypic analysis of a B cell clone with anti-intermediate filament specificity in a patient with Sjögren's syndrome: involvement of five subpopulations producing different immunoglobulin isotypes.
    Landay A; Kubagawa H; Cooper MD
    J Immunol; 1986 Jul; 137(1):129-36. PubMed ID: 3086445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-existent anti-La antibodies and rheumatoid factors bear distinct idiotypic markers.
    Horsfall AC; Venables PJ; Allard SA; Maini RN
    Scand J Rheumatol Suppl; 1988; 75():84-8. PubMed ID: 3070730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantigen-specific memory B cells in primary Sjögren's syndrome.
    Aqrawi LA; Skarstein K; Bredholt G; Brun JG; Brokstad KA
    Scand J Immunol; 2012 Jan; 75(1):61-8. PubMed ID: 21916919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At least three distinct B cell epitopes reside in the C-terminal half of La protein, as determined by a recombinant DNA approach.
    Rauh AJ; Hornig H; Lührmann R
    Eur J Immunol; 1988 Dec; 18(12):2049-57. PubMed ID: 2464497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late development of anti-La/SS-B antibodies in a patient with Sjogren's syndrome and high titer anti-Ro/SS-A antibodies.
    Satoh M; Hamilton KJ; Langdon JJ; Akizuki M; Yamagata H; Nakayama S; Reeves WH; Homma M
    Lupus; 1996 Aug; 5(4):337-9. PubMed ID: 8869909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity.
    Rubin RL; Tang FL; Chan EK; Pollard KM; Tsay G; Tan EM
    J Immunol; 1986 Oct; 137(8):2528-34. PubMed ID: 3760566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
    Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
    Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus.
    Hoffman RW
    Arthritis Rheum; 2007 Oct; 56(10):3180-2. PubMed ID: 17907162
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of anti-DNA antibody production in MRL mice by treatment with anti-idiotypic antibodies.
    Mahana W; Guilbert B; Avrameas S
    Clin Exp Immunol; 1987 Dec; 70(3):538-45. PubMed ID: 3501743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2.
    Fox RI; Theofilopoulos AN; Altman A
    J Immunol; 1985 Nov; 135(5):3109-15. PubMed ID: 3876375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody production in Sjögren's syndrome: a hypothesis regarding defects in somatic diversification of germ line encoded genes.
    Fox RI; Fong S; Chen PP; Kipps TJ
    In Vivo; 1988; 2(1):47-55. PubMed ID: 2979816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome.
    Nakamura H; Kawakami A; Eguchi K
    Transl Res; 2006 Dec; 148(6):281-8. PubMed ID: 17162248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.